(Q44175378)

30 November 2017

title

Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation (English)

1 reference

30 November 2017

main subject

liver transplantation

1 reference

T M Antonini

1

1 reference

30 November 2017

M Sebagh

2

1 reference

30 November 2017

A M Roque-Afonso

3

1 reference

30 November 2017

E Teicher

4

1 reference

30 November 2017

B Roche

5

1 reference

30 November 2017

R Sobesky

6

1 reference

30 November 2017

A Coilly

7

1 reference

30 November 2017

P Vaghefi

8

1 reference

30 November 2017

R Adam

9

1 reference

30 November 2017

D Vittecoq

10

1 reference

30 November 2017

D Castaing

11

1 reference

30 November 2017

D Samuel

12

1 reference

30 November 2017

J-C Duclos-Vallée

13

1 reference

30 November 2017

language of work or name

English

0 references

publication date

12 July 2011

1 reference

American Journal of Transplantation

30 November 2017

published in

1 reference

30 November 2017

volume

11

1 reference

30 November 2017

issue

8

1 reference

30 November 2017

page(s)

1686-1695

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

30 November 2017

1 reference

Projections of global mortality and burden of disease from 2002 to 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Are HIV-infected patients candidates for liver transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Early HCV-associated stellate cell activation in aggressive recurrent HCV: what can liver allografts teach about HCV pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03608.X

10.1111/J.1600-6143.2011.03608.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference